NFSA-DTI:一种使用神经指纹和自我注意机制的新型药物向相互作用预测模型
Feiyang Liu1, Huang Xu1, Peng Cui1
1School of Information, Guizhou University of Finance and Economics, Guiyang 550025, China.
International journal of molecular sciences
|November 9, 2024
概括
本研究介绍了NFSA-DTI,这是一个新的深度学习模型,通过整合全球和本地特征来预测药物向相互作用. NFSA-DTI提高了预测准确度,并为药物发现提供了分子层面的洞察力.
科学领域:
- 计算化学是一种计算化学.
- 生物信息学是一种生物信息学.
- 药物发现 药物发现
背景情况:
- 深度学习模型擅长预测药物向相互作用 (DTI).
- 现有的方法往往忽略了全球特征,或不充分模拟关键的交互站点.
- 局限性包括过度依赖本地特征和不充分建模交互站点.
研究的目的:
- 提出一种新的深度学习模型,NFSA-DTI,用于增强药物向相互作用预测.
- 有效地整合药物分子和向序列的本地和全球特征.
- 改进药物标对关键相互作用部位的建模.
主要方法:
- 利用神经指纹来提取全球药物特征.
- 采用自我注意机制来增强CNN在目标序列中的长距离依赖性.
- 改进了双线性注意网络,用于学习本地交互网站的注意聚合.
主要成果:
- 与基线模型相比,NFSA-DTI在三个基准数据集上表现出优异的预测性能.
- 实验结果证实了该模型在DTI预测中的有效性.
- 案例研究为药物发现提供了宝贵的见解.
结论:
- NFSA-DTI有效地整合了全球和本地特征,以准确预测药物向相互作用.
- 该模型提供了分子层次的解释,帮助药物发现过程.
- NFSA-DTI代表了计算药物发现的重大进步.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
643
相关概念视频
Drug-Receptor Interaction: Antagonist
2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
